← Back to Clinical Trials
Recruiting NCT04093388
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
Trial Parameters
Condition Cervical Cancer
Sponsor University of Alabama at Birmingham
Study Type INTERVENTIONAL
Phase N/A
Enrollment 250
Sex FEMALE
Min Age 21 Years
Max Age 65 Years
Start Date 2021-04-26
Completion 2026-12-31
Interventions
Self-PAPTraditional Pap smear
Brief Summary
The purpose of the study is to find out if a self-administered (by the patient) Papanicolaou (Pap) smear is as accurate as a traditional Pap smear administered by a healthcare provider.
Eligibility Criteria
Inclusion Criteria: * Female of at least 21 years of age and not over 65 presenting who need routine cervical cancer screening per national guidelines. Exclusion Criteria: * prior history of cervical cancer or a positive Pap smear, have had a total hysterectomy (removal of uterus and cervix), or currently enrolled in any other cancer prevention study.
Related Trials
NCT06455072
Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer
View Trial →
NCT05366881
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Dis
View Trial →
NCT06619002
Implementation of Surgical Safety and Intraoperative Metastasis Identification Through Deep Learning
View Trial →